Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 77001-77050 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05649605
Early Mental Response - The EMRE Study
NARecruiting
70 participants
Started: Mar 7, 2023 · Completed: Dec 30, 2026
3 conditions1 sponsor1 location
NCT05554068
Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
PHASE2Recruiting
100 participants
Started: Mar 7, 2023 · Completed: Nov 1, 2026
1 condition1 sponsor1 location
NCT05788835
DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial
NARecruiting
220 participants
Started: Mar 7, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor16 locations
NCT06337643
A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine
PHASE1Active, not recruiting
75 participants
Started: Mar 7, 2023 · Completed: Apr 16, 2024
1 condition1 sponsor2 locations
NCT05773612
Rock Steady Boxing: A Community Based In Person Class
NARecruiting
150 participants
Started: Mar 7, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05686226
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
PHASE2Recruiting
20 participants
Started: Mar 7, 2023 · Completed: Jan 1, 2027
21 conditions3 sponsors2 locations
NCT06238674
Early Goal Nutrition Therapy Guided by Indirect Calorimetry and Nitrogen Balance Among Critically Ill Patients With Acute Kidney Injury (ENGINE Study)
PHASE1/PHASE2Active, not recruiting
80 participants
Started: Mar 7, 2023 · Completed: Mar 28, 2024
3 conditions2 sponsors1 location
NCT05777005
Promoting Smoking Cessation in Campus
NARecruiting
150 participants
Started: Mar 6, 2023 · Completed: Dec 30, 2024
2 conditions1 sponsor1 location
NCT05927298
Province of Ontario Strategy for Personalized Management of Pancreatic Cancer Trial
N/ARecruiting
200 participants
Started: Mar 6, 2023 · Completed: Mar 6, 2027
1 condition4 sponsors1 location
NCT05625399
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
PHASE3Active, not recruiting
579 participants
Started: Mar 6, 2023 · Completed: Nov 18, 2027
1 condition1 sponsor149 locations
NCT04407611
Scalable Communication Modalities for Returning Genetic Research Results
NAActive, not recruiting
932 participants
Started: Mar 6, 2023 · Completed: Nov 30, 2025
2 conditions4 sponsors1 location
NCT05731960
Evaluating the Effect of Intravenous Dexamethasone on the Duration of Spinal Anesthesia After Cesarean Delivery
PHASE4Recruiting
192 participants
Started: Mar 6, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05286112
Mindfulness for Pain and Suicide
NAActive, not recruiting
76 participants
Started: Mar 6, 2023 · Completed: Feb 28, 2025
4 conditions2 sponsors1 location
NCT05657106
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
NAActive, not recruiting
752 participants
Started: Mar 6, 2023 · Completed: Jul 31, 2027
8 conditions2 sponsors1 location
NCT05327062
Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
NARecruiting
150 participants
Started: Mar 6, 2023 · Completed: Sep 30, 2025
3 conditions1 sponsor13 locations
NCT05660967
Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma
PHASE2Active, not recruiting
111 participants
Started: Mar 6, 2023 · Completed: Jul 31, 2027
1 condition2 sponsors74 locations
NCT05742802
Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).
PHASE3Recruiting
1,869 participants
Started: Mar 6, 2023 · Completed: Aug 17, 2026
1 condition1 sponsor389 locations
NCT05618054
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
NARecruiting
36 participants
Started: Mar 6, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06309810
Stereotactic Radiosurgery (SRS) in Malignant Spasticity and Hypertonia
NARecruiting
10 participants
Started: Mar 6, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05710861
Cost-utility of Focal HIFU vs Prostatectomy
NARecruiting
346 participants
Started: Mar 6, 2023 · Completed: Jun 22, 2028
1 condition1 sponsor20 locations
NCT05521776
Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)
NARecruiting
14,500 participants
Started: Mar 6, 2023 · Completed: Mar 6, 2026
1 condition3 sponsors22 locations
NCT05526755
A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)
PHASE2Active, not recruiting
188 participants
Started: Mar 6, 2023 · Completed: Nov 22, 2029
1 condition1 sponsor56 locations
NCT05643092
Biomarker and Imaging Package Study in Immune Effector Cell-Associated Neurotoxicity Syndrome
N/ARecruiting
50 participants
Started: Mar 6, 2023 · Completed: Dec 31, 2027
1 condition3 sponsors1 location
NCT06321783
Relationship Between Cervical Proprioception and Endurance With Hand-eye Coordination and Postural Control
NARecruiting
100 participants
Started: Mar 6, 2023 · Completed: Sep 6, 2024
1 condition1 sponsor1 location
NCT05373823
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
NARecruiting
385 participants
Started: Mar 6, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05774093
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
N/ARecruiting
300 participants
Started: Mar 6, 2023 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT05700071
MRS of Glioma Genomics
NARecruiting
80 participants
Started: Mar 6, 2023 · Completed: Mar 2, 2028
1 condition1 sponsor2 locations
NCT06103357
Identification of Biomarkers in Subjects With Coronary Syndrome (PLAQUE Study)
N/ARecruiting
20 participants
Started: Mar 6, 2023 · Completed: Apr 30, 2024
1 condition2 sponsors1 location
NCT05647564
PET/CT Characterization of Treatment Resistance
NARecruiting
20 participants
Started: Mar 6, 2023 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT05677971
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
PHASE3Recruiting
160 participants
Started: Mar 6, 2023 · Completed: Aug 14, 2030
1 condition2 sponsors82 locations
NCT05755087
Tegavivint for Treating Patients with Relapsed or Refractory Large B-Cell Lymphoma
PHASE1Recruiting
20 participants
Started: Mar 6, 2023 · Completed: Mar 5, 2027
9 conditions1 sponsor1 location
NCT05892250
Dynamic Humeral Centering Exercises in Subacromial Pain Syndrome
NARecruiting
84 participants
Started: Mar 6, 2023 · Completed: Dec 18, 2025
2 conditions1 sponsor1 location
NCT05653349
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
PHASE3Active, not recruiting
226 participants
Started: Mar 6, 2023 · Completed: Dec 18, 2028
1 condition1 sponsor124 locations
NCT06875336
A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis
N/ARecruiting
150 participants
Started: Mar 6, 2023 · Completed: Dec 31, 2025
1 condition8 sponsors6 locations
NCT05433415
Black Girls Move Physical Activity and Improving Dietary Intake Among Black Adolescent Daughters
NAActive, not recruiting
120 participants
Started: Mar 6, 2023 · Completed: Nov 30, 2025
2 conditions4 sponsors1 location
NCT05169112
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy
PHASE3Recruiting
72 participants
Started: Mar 6, 2023 · Completed: Nov 30, 2028
1 condition2 sponsors3 locations
NCT05740202
A Trial of SHR-7367 in Subjects With Advanced Solid Tumors
PHASE1Active, not recruiting
22 participants
Started: Mar 6, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05606614
Safety and Efficacy of TSHA-102 in Adolescent and Adult Females With Rett Syndrome (REVEAL Adult Study)
PHASE1/PHASE2Recruiting
18 participants
Started: Mar 6, 2023 · Completed: Jan 5, 2032
1 condition1 sponsor6 locations
NCT05390411
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
NAEnrolling by invitation
1,463 participants
Started: Mar 6, 2023 · Completed: Jan 3, 2028
3 conditions2 sponsors1 location
NCT05913791
Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With Eczema
NAActive, not recruiting
41 participants
Started: Mar 6, 2023 · Completed: Jan 31, 2025
4 conditions2 sponsors1 location
NCT06705244
Trans-nasal Sphenopalatine Ganglion Block Versus Ultrasound-guided Bilateral Greater and Lesser Occipital Nerve Block for Management of Post-Dural Puncture Headache.
NAActive, not recruiting
50 participants
Started: Mar 6, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05878236
iMmune SignAtures and Clinical outComes in AP
N/ARecruiting
198 participants
Started: Mar 6, 2023 · Completed: Dec 31, 2027
1 condition5 sponsors5 locations
NCT05811351
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
PHASE2Active, not recruiting
305 participants
Started: Mar 6, 2023 · Completed: Feb 26, 2026
1 condition1 sponsor162 locations
NCT05793489
Prospective Double Arm Randomized Trial: WBRT Alone and WBRT Plus Silibinin
NAActive, not recruiting
44 participants
Started: Mar 6, 2023 · Completed: Mar 30, 2026
1 condition2 sponsors1 location
NCT05784311
Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)
PHASE4Recruiting
344 participants
Started: Mar 6, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor11 locations
NCT06204822
Non-contact Blood Pressure and SpO2 Measurement Based on Image Sensor
N/ARecruiting
200 participants
Started: Mar 6, 2023 · Completed: Mar 6, 2026
2 conditions1 sponsor1 location
NCT05808387
The Effects of Resveratrol on Sirtuins and Apoptosis Biomarkers
NARecruiting
80 participants
Started: Mar 6, 2023 · Completed: Jun 5, 2026
3 conditions1 sponsor1 location
NCT05975437
Effectiveness of Personalized Surveillance and Aftercare for Breast Cancer
N/AEnrolling by invitation
1,040 participants
Started: Mar 6, 2023 · Completed: Mar 6, 2027
3 conditions5 sponsors10 locations
NCT05963308
Promoting Sustainable Return to Work Among Employees on Sick Leave Due to a Mental Health Condition: Evaluation of the HealthyMinds Online Group Intervention
NARecruiting
80 participants
Started: Mar 6, 2023 · Completed: Mar 1, 2025
4 conditions4 sponsors1 location
NCT06087016
Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers
N/ARecruiting
1,800 participants
Started: Mar 6, 2023 · Completed: Mar 6, 2026
1 condition1 sponsor1 location